{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T04:07:05Z","timestamp":1771301225202,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.intimp.2015.02.018","type":"journal-article","created":{"date-parts":[[2015,2,21]],"date-time":"2015-02-21T14:42:19Z","timestamp":1424529739000},"page":"393-399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["5-Aminoimidazole-4-carboxamide-1-\u03b2-d-ribofuranoside alleviated carbon tetrachloride-induced acute hepatitis in mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Changming","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianqiong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pu","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2015.02.018_bb0005","first-page":"295","article-title":"Acute-on-chronic liver failure: a review","volume":"10","author":"Zamora Nava","year":"2014","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.intimp.2015.02.018_bb0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/713611034","article-title":"Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model","volume":"33","author":"Weber","year":"2003","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0300-483X(03)00157-4","article-title":"Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients","volume":"189","author":"Basu","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.intimp.2015.02.018_bb0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.fct.2013.11.006","article-title":"The involvement of Nrf2 in the protective effects of diallyl disulfide on carbon tetrachloride-induced hepatic oxidative damage and inflammatory response in rats","volume":"63","author":"Lee","year":"2014","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0025","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1124\/jpet.107.128264","article-title":"Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor","volume":"323","author":"Horrillo","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2015.02.018_bb0030","first-page":"30","article-title":"Changing the energy of an immune response","volume":"2","author":"Delmastro-Greenwood","year":"2013","journal-title":"Am J Clin Exp Immunol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0035","doi-asserted-by":"crossref","first-page":"22893","DOI":"10.1074\/jbc.R113.486464","article-title":"How metabolism generates signals during innate immunity and inflammation","volume":"288","author":"McGettrick","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2015.02.018_bb0040","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.chembiol.2012.08.019","article-title":"AMP-activated protein kinase: a target for drugs both ancient and modern","volume":"19","author":"Hardie","year":"2012","journal-title":"Chem Biol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0045","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1042\/BST20130030","article-title":"The kinase triad, AMPK, mTORC1 and ULK1, maintains energy and nutrient homoeostasis","volume":"41","author":"Dunlop","year":"2013","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.intimp.2015.02.018_bb0050","doi-asserted-by":"crossref","first-page":"19051","DOI":"10.1074\/jbc.M110.123620","article-title":"Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1","volume":"285","author":"Yang","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2015.02.018_bb0055","doi-asserted-by":"crossref","first-page":"1242454","DOI":"10.1126\/science.1242454","article-title":"Fueling immunity: insights into metabolism and lymphocyte function","volume":"342","author":"Pearce","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.intimp.2015.02.018_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cbi.2014.03.013","article-title":"Involvement of catalase in the protective benefits of metformin in mice with oxidative liver injury","volume":"216","author":"Dai","year":"2014","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.intimp.2015.02.018_bb0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bcp.2013.05.023","article-title":"AMP-activated protein kinase: a target for old drugs against diabetes and cancer","volume":"86","author":"Russo","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0070","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1172\/JCI40671","article-title":"Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state","volume":"120","author":"Foretz","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2015.02.018_bb0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.taap.2013.05.010","article-title":"Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways","volume":"271","author":"Do","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.vph.2011.10.003","article-title":"AMP-activated protein kinase and the control of smooth muscle cell hyperproliferation in vascular disease","volume":"56","author":"Ferri","year":"2012","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0085","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/CS20080066","article-title":"AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease","volume":"116","author":"Wong","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.intimp.2015.02.018_bb0090","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1432-1033.1995.tb20498.x","article-title":"5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?","volume":"229","author":"Corton","year":"1995","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.intimp.2015.02.018_bb0095","doi-asserted-by":"crossref","first-page":"25956","DOI":"10.1074\/jbc.M602992200","article-title":"5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes","volume":"281","author":"Gaidhu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2015.02.018_bb0100","doi-asserted-by":"crossref","first-page":"L497","DOI":"10.1152\/ajplung.90210.2008","article-title":"Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury","volume":"295","author":"Zhao","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0105","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.bcp.2010.08.009","article-title":"AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis","volume":"80","author":"Bai","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0110","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jhep.2004.11.043","article-title":"Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression","volume":"42","author":"Bansal","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0115","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI10613","article-title":"Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice","volume":"107","author":"Sass","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2015.02.018_bb0120","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2174\/156652407782564363","article-title":"Nuclear factor-kappa B: from clone to clinic","volume":"7","author":"Ahn","year":"2007","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.intimp.2015.02.018_bb0125","first-page":"2571","article-title":"Matrix metalloproteinases in inflammation","volume":"2014","author":"Nissinen","year":"1840","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.intimp.2015.02.018_bb0130","doi-asserted-by":"crossref","first-page":"H84","DOI":"10.1152\/ajpheart.00749.2010","article-title":"Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival","volume":"300","author":"Liu","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0135","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.2337\/db08-1512","article-title":"Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin","volume":"58","author":"Li","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2015.02.018_bb0140","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/CIRCRESAHA.109.212530","article-title":"AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes","volume":"106","author":"Wang","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.intimp.2015.02.018_bb0145","first-page":"241","article-title":"The roles of innate immune cells in liver injury and regeneration","volume":"4","author":"Dong","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0150","doi-asserted-by":"crossref","first-page":"e86881","DOI":"10.1371\/journal.pone.0086881","article-title":"AMPK inhibition blocks ROS-NFkappaB signaling and attenuates endotoxemia-induced liver injury","volume":"9","author":"Guo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2015.02.018_bb0155","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/jcb.21466","article-title":"Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase","volume":"103","author":"Kuo","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.intimp.2015.02.018_bb0160","doi-asserted-by":"crossref","first-page":"e49935","DOI":"10.1371\/journal.pone.0049935","article-title":"The full capacity of AICAR to reduce obesity-induced inflammation and insulin resistance requires myeloid SIRT1","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2015.02.018_bb0165","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1074\/jbc.M112.413138","article-title":"AMP-activated protein kinase activation by 5-aminoimidazole-4-carbox-amide-1-beta-D-ribofuranoside (AICAR) reduces lipoteichoic acid-induced lung inflammation","volume":"288","author":"Hoogendijk","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2015.02.018_bb0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1582-4934.2004.tb00469.x","article-title":"Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury","volume":"8","author":"Ding","year":"2004","journal-title":"J Cell Mol Med"},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2015.02.018_bb0175","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1111\/j.1440-1746.2006.04645.x","article-title":"Tumor necrosis factor signaling in hepatocyte apoptosis","volume":"22","author":"Hatano","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0180","doi-asserted-by":"crossref","first-page":"e11256","DOI":"10.1371\/journal.pone.0011256","article-title":"Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice","volume":"5","author":"de Meijer","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2015.02.018_bb0185","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nm1101-1202","article-title":"Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy","volume":"7","author":"Wielockx","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.intimp.2015.02.018_bb0190","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1872-034X.2009.00541.x","article-title":"Matrix metalloproteinase inhibitor, CTS-1027, attenuates liver injury and fibrosis in the bile duct-ligated mouse","volume":"39","author":"Kahraman","year":"2009","journal-title":"Hepatol Res"},{"key":"10.1016\/j.intimp.2015.02.018_bb0195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tips.2013.02.004","article-title":"Missing the target: matrix metalloproteinase antitargets in inflammation and cancer","volume":"34","author":"Dufour","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.intimp.2015.02.018_bb0200","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1478-3231.2008.01775.x","article-title":"Contribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure","volume":"28","author":"Yan","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.intimp.2015.02.018_bb0205","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/bjp.2008.338","article-title":"The antioxidant activity of chondroitin-4-sulphate, in carbon tetrachloride-induced acute hepatitis in mice, involves NF-kappaB and caspase activation","volume":"155","author":"Campo","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0210","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jhep.2007.07.024","article-title":"Epimorphin, a morphogenic protein, induces proteases in rodent hepatocytes through NF-kappaB","volume":"47","author":"Miura","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0215","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4161\/viru.23354","article-title":"Toll-like receptor signaling and regulation of intestinal immunity","volume":"4","author":"Kamdar","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.intimp.2015.02.018_bb0220","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tcb.2012.08.001","article-title":"The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation","volume":"22","author":"Tornatore","year":"2012","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0225","doi-asserted-by":"crossref","first-page":"791231","DOI":"10.1155\/2013\/791231","article-title":"Inflammatory signalings involved in airway and pulmonary diseases","volume":"2013","author":"Lee","year":"2013","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.intimp.2015.02.018_bb0230","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00109-011-0748-0","article-title":"AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan","volume":"89","author":"Salminen","year":"2011","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.intimp.2015.02.018_bb0235","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.phrs.2012.10.010","article-title":"Negative regulation of inflammation by SIRT1","volume":"67","author":"Xie","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.intimp.2015.02.018_bb0240","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1189\/jlb.1112557","article-title":"Sirtuin deacylases: a molecular link between metabolism and immunity","volume":"93","author":"Preyat","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.intimp.2015.02.018_bb0245","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.devcel.2008.02.004","article-title":"Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt","volume":"14","author":"Fulco","year":"2008","journal-title":"Dev Cell"},{"key":"10.1016\/j.intimp.2015.02.018_bb0250","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity","volume":"458","author":"Canto","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2015.02.018_bb0255","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1124\/jpet.111.184242","volume":"339","author":"Bumpus","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2015.02.018_bb0260","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1074\/jbc.M113.528232","article-title":"5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo","volume":"289","author":"Hasenour","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2015.02.018_bb0265","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2337\/diabetes.55.04.06.db05-1178","article-title":"5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation","volume":"55","author":"Guigas","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2015.02.018_bb0270","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1074\/jbc.M605702200","article-title":"Inhibition of hepatic phosphatidylcholine synthesis by 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside is independent of AMP-activated protein kinase activation","volume":"282","author":"Jacobs","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2015.02.018_bb0275","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bcp.2014.07.010","article-title":"AICAR induces Nrf2 activation by an AMPK-independent mechanism in hepatocarcinoma cells","volume":"91","author":"Sid","year":"2014","journal-title":"Biochem Pharmacol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691500065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691500065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:14Z","timestamp":1537833614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757691500065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S156757691500065X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2015.02.018","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Aminoimidazole-4-carboxamide-1-\u03b2-d-ribofuranoside alleviated carbon tetrachloride-induced acute hepatitis in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2015.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}